The pattern analysis results for EGFRvIII(−) GBM patient single-cell data (Fig. S2A) revealed that in the outgoing pattern analysis, tumor cells dominated Pattern2, with the MDK signaling pathway being the most active in Pattern2. This evidence concerns the gene MDK and glioblastoma.